Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teicoplanin PK/PD study in critically ill adults with infection
ChiCTR1800019344Phase 4Recruiting
- Sponsor
- Guangdong Provincial People's Hospital
- Start
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of teicoplanin in Gram-positive bacterial infection, Airways Infection, bloodstream infection (BSI) and 6 more (2 cohorts), sponsored by Guangdong Provincial People's Hospital. Primary endpoint: Plasma concentration of teicoplanin. Started Dec 2018; status: recruiting.
02
Drugs
teicoplanin
03
Conditions
Gram-positive bacterial infectionAirways Infectionbloodstream infection (BSI)catheter infectionendocarditis (IE)
Beyond the preview
Go deeper on ChiCTR1800019344.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800019344.